Federation des caisses Desjardins du Quebec’s Actinium Pharmaceuticals ATNM Stock Holding History

Federation des caisses Desjardins du Quebec’s Portfolio ATNM Stock Details ATNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,300	Closed	-$13.8K	–	2349
2022 Q4	$13.8K	Hold	1,300	–	–	﹤0.01%	1789
2022 Q3	$9.59K	Hold	1,300	–	–	﹤0.01%	1928
2022 Q2	$6.25K	Hold	1,300	–	–	﹤0.01%	2064
2022 Q1	$6.64K	Hold	1,300	–	–	﹤0.01%	2137
2021 Q4	$7.81K	Sell	1,300 -800	-38%	-$6K	﹤0.01%	2095
2021 Q3	$18.6K	Buy	+2,100	New	+$14.6K	﹤0.01%	1879

Other funds holding ATNM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sentinus LLC Oak Brook, Illinois $1.11B AUM 17.13% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Federation des caisses Desjardins du Quebec's ATNM Position: Q1 2023 in Review

Federation des caisses Desjardins du Quebec sold out of Actinium Pharmaceuticals (ATNM) in Q1 2023, closing a stake of 1,300 shares — an estimated $13.8K sold.

Federation des caisses Desjardins du Quebec first reported a position in ATNM in Q3 2021 and held it in 6 quarters. The position peaked at $18.6K in Q3 2021. 64 funds tracked by Wall St. Rank hold ATNM as of Q1 2023.

Federation des caisses Desjardins du Quebec reported no remaining Actinium Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
Federation des caisses Desjardins du Quebec sold 1,300 Actinium Pharmaceuticals shares in Q1 2023, an estimated $13.8K.
Federation des caisses Desjardins du Quebec first reported a position in Actinium Pharmaceuticals in Q3 2021 and held it in 6 quarters.
Federation des caisses Desjardins du Quebec's Actinium Pharmaceuticals position peaked at $18.6K in Q3 2021.
64 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q1 2023.

Based on Federation des caisses Desjardins du Quebec's 13F filing for Q1 2023, filed 15 Aug 2024.